5 deaths that forced Japan to inspect another factory for "Kobayashi" business

The Japanese health authorities searched a second factory for Kobayashi Pharmaceutical in western Japan on Sunday, after five deaths are likely to be associated with eating food supplements, according to an official at the Ministry of Health. The Wakayama Province inspection comes after the first inspection of the seeker on Saturday in Osaka to expand an investigation into the use of the Red Pharmaceutical Pharmaceutical Company in producing a food supplement known as “Benny Koji”. “Osaka, based in Osaka, says it appears to be the poison bobyrulic acid that could be of blue Penicillium form in the” Benny Koji “components produced in the Osaka factory between April and October 2023. is, what was to market as marketing to market, and it was marketed after feeding the nutrition. The government has criticized the company for taking two months to announce the health effects of its products. ‘Kobayshi’ started withdrawing the products on March 22 after receiving reports on kidney tools. The company’s products are also consumed in other countries. Japanese media reported that a serious kidney failure was reported in Taiwan. The Japanese Broadcasting and Television Corporation said that “Kobaysshi” Benny Koji sold in bulk for about 52 companies, which did voluntary inspections, and that they only found any material that needed medical advice on Friday. She added that these businesses sell this material to 173 other businesses. Japanese “Ashay” TV reported that about 1,800 food manufacturing companies could be affected. Earlier on Thursday, Japanese government spokesman Yoshimasa Hayashi said: “The ministries and bodies involved work together to ensure food safety, and in this context they try to determine the substance that causes health damage and understand how it is in the product.” Hayachi added at a press conference that the government also asked manufacturers of other nutritional supplements to verify their products, and work to inform abroad of this health problem.